Introduction. Colorectal cancer (CRC) prevention programs using fecal immunochemical
testing (FIT) in screening rely on colonoscopy for secondary and surveillance testing …

Background Immunochemical faecal testing (FIT) is used in Canada for colorectal cancer
(CRC) screening. The threshold for FIT abnormality is under operator control and this study …

Objective Annual fecal immunochemical tests can reduce colorectal cancer incidence and
mortality. However, screening is a multi-step process and most patients do not perfectly …

Aim The aim was to use newly available data to estimate the cost effectiveness and
endoscopy requirements of screening options for colorectal cancer (CRC) to inform …

Background The ColonCancerCheck screening program for colorectal cancer (CRC) in
Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test …

For individuals willing to minimize their lifetime risk of colorectal cancer (CRC), the most
effective screening approach remains unclear. Here, we sought to compare the long‐term …

Background and aims: Current guidelines recommend colonoscopy every 3–5 years for
colorectal cancer (CRC) screening of individuals with a familial history of CRC. The …

Background: Colorectal cancer (CRC) is a major cause of morbidity and mortality in France.
Only scanty data on cost-effectiveness of CRC screening in Europe are available …

Introduction To reduce the burden of colorectal cancer (CRC) in Shanghai, China, a CRC
screening programme was commenced in 2013 inviting those aged 50–74 years to triennial …

Objectives In 2016, it was announced that the fecal immunochemical test (FIT) would
replace the guaiac fecal occult blood test in the UK Bowel Cancer Screening Programme …